Shingles Vaccination Linked to Lower Dementia Risk
Research Overview
Recent studies indicate that older adults who receive the shingles vaccine may experience a reduced risk of developing dementia. The investigation into the shingles vaccine’s benefits has extended beyond its primary purpose of preventing herpes zoster to include its potential impact on various medical conditions.
Previous Findings
Research has shown that the shingles vaccine may play a role in preventing cardiovascular issues, including heart disease and stroke. Notably, a study published in January 2026 suggested that the shingles vaccine could even contribute to slowing biological aging.
Dementia Prevention Studies
The link between shingles vaccination and dementia prevention has garnered significant attention. A study published in October 2025 indicated that the vaccine might offer protection against vascular dementia. Moreover, additional research from December 2025 highlighted the vaccine’s potential to lower dementia risk and slow disease progression.
Latest Research Insights
The latest study, published in the journal The Lancet, adds to the growing body of evidence suggesting that receiving the shingles vaccine may help delay or reduce the diagnosis of dementia in older adults. This ongoing research emphasizes the importance of the shingles vaccine in promoting overall cognitive health.